Archive for September, 2013
Recent Rosacea Blog Posts
Mirvaso is so new that only a few rosacea sufferers have been able to try it. What are your chances of having a bad reaction ? How are users in the real world faring, and will the general population see the same level of benefits as the large number of Phase III trialists ? So […]
As is the case for many of the prescriptions targeted at rosacea, the manufacturers of Mirvaso have made available a Mirvaso Coupon program. Galderma calls their Mirvaso campaign the Mirvaso Cost Reduction Card. The tagline for the promotion is “Eligible insured patients MAY pay no more than $50 for each Mirvaso Topical Gel prescription”. […]
A really interesting post over at `medpage TODAY’ is asking just what is the American Acne & Rosacea Society is up to, and asking the question are they too close to the bigPharma that they are funded by. We first learned of the existence of the AARS in 2006. Whilst it was puzzling as to […]
Galderma is claiming that the following patents protect their recently FDA Approved Brimonidine Gel known as Mirvaso. These patents are quoted in the Mirvaso Prescribing Information thus forming a public statement by Galderma to any would be competitors. Note one patent is for using Mirvaso to treat the broken blood vessels of rosacea (telangiectasis). This […]
An interesting graph published on the NRS Blog shows that there is a high concentration of rosacea sufferers in the North East of the USA. The graph shows the residents of New England have the highest incidence of rosacea in the country. Puts a different spin on red states vs. blue states eh? The NRS […]
